Timothy Simon

Timothy Simon is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as Vice President of Business Development and Corporate Strategy at UroGen Pharma since July 2023, while also contributing as a Board Member at Med Learning Group since January 2023. Previously, Timothy held the position of Managing Director Consultant at Accenture from September 2021 to April 2024, specializing in Oncology and Hematology. Notable past roles include Senior Vice President and Chief Commercial Officer at both HUYA Bioscience International and Melinta Therapeutics, as well as Vice President and Franchise Head for Oncology at Pfizer. At GSK, Timothy served in multiple capacities, including Global Product Launch Lead and Vice President of Field Sales. Timothy began their career at Johnson & Johnson, progressing through various marketing roles focused on Hematology and Oncology. Timothy holds an MBA in Marketing from Penn State University and a B.A. in Biology from the University of Delaware.